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Abstract

A new class of fluorescent dyes, pyridoimidiazolium cations, is being considered
for their possible use in the biochemical field because of their interactions with DNA.
Binding of low molecular weight fluorophores has been proven to cause a wide variety of
biological responses in DNA. The dyes used here have been synthesized using α-diimine
type compounds. The reaction used has the capability to produce many fluorescent
cations. Binding constants of these compounds in acetonitrile with calf thymus DNA
have been determined by measuring emission intensity. Emission intensity showed the
degree to which binding is occurring. The experimental results show that binding is
occurring among all of the fluorophores studied and calf thymus DNA. Binding is
proven in the decrease in emission, with one exception, seen upon each addition of DNA.
The one fluorophore which differed showed an increase in emission intensity, to a certain
concentration of DNA, at which it behaved as the rest and decreased. The experimental
results also show that there is no generalization that can be made when trying to correlate
the binding constants with the type of binding that is occurring between these
fluorophores and DNA, intercalation or nonintercalation.
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Introduction
The binding of fluorescent dyes to DNA has attracted much attention in recent
years due to their use in the medical field and the biological response that occurs in DNA
upon binding of fluorescent dyes. The range of applications is vast and includes
oncological, infectious, and genetically determined diseases.1,2,3 There are many cancers
that do not respond to chemotherapy so a need still exists for antitumor drugs,
specifically drugs that interact with DNA.4 Studying different dyes to determine site
specific binding is important in the development of novel chemotherapeutics and
diagnostic agents. These binding ligands are molecules that interact strongly with a
specific site of the DNA. For medicinal use, the molecules must have a large binding
constant and also have the ability to be detected once the binding has occurred.
The optical properties of the dyes change upon binding to DNA. Fluorescent
quantum yields can increase or decrease, but any change in fluorescent intensity indicates
binding has occurred. Other properties to look for in the spectra can be a red shift in the
excitation or emission spectra. None of these changes in spectra can be generalized for
all dyes.
Intercalating/Nonintercalating
Fluorescent dyes (probes) that bind to DNA are placed into two categories:
intercalating and nonintercalating. Intercalation into DNA consists of the dyes fitting
between adjacent base pairs of DNA. The dye is almost perpendicular to the DNA helix
axis and is in close contact with the DNA base pairs.5 Aromatic stacking interactions
exist between the DNA base pairs and the dye molecule, and also occur between the
DNA base pairs themselves.
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DNA(Figure 1) consists of 4 nucleic acids: Guanine, Cytosine, Adenine, and
Thymine. They are bonded together through ribose sugars, phosphate groups, and
hydrogen bonding. The base pairs are G-C, and A-T. The phosphate groups and ribose
sugars make up the backbone of each single strand of DNA, whereas hydrogen bonding
occurs in the double helix. Figure 1 depicts the chemical composition of DNA.

Figure 1: Chemical composition of DNA
An intercalating dye would fit between stacked base pairs. Bulkiness of the dye
and hydrogen bonding play a role in how well it fits. The base pairs are held together via
hydrogen bonds. Guanine and Cytosine are held together through three hydrogen bonds
while Adenine and Thymine are held together with two hydrogen bonds. This makes
Guanine and Cytosine more difficult to separate which makes binding, of dyes, different
for different types of DNA due to the ability of some ligands to better bind to DNA with
smaller G-C content. The intercalating dyes do not break the double bonds, but the more
hydrogen bonding that occurs, the more difficult it becomes to unwind, or create space,
for the dye to fit between base pairs.
2

Nonintercalating dyes, due to bulkiness and other factors, bind to the outside of
the bihelical structure.4 This is done through groove binding or electrostatic binding.
Groove binding involves elongated crescent shaped molecules interacting with base pairs
in either the major or minor grooves of DNA. This process widens the groove but does
not elongate or unwind the double helix. In electrostatic binding, a cationic molecule is
attracted to the anionic surface of DNA. These cations form ionic or hydrogen bonds
along the outside of the DNA double helix.
Many factors affect whether a dye is intercalating or nonintercalating. These
include structure, solution conditions (ionic strength, pH, and temperature), and the local
DNA sequence.6 Dye structure plays an important role because of the tendency of planar
molecules to stack between base pairs whereas molecules with bulkier substituents stay
on the outside or semi-intercalate.5
Intercalating ligands bind much more strongly to DNA than nonintercalating or
semi-intercalating ligands. One study examined the effects of binding for two similar
ligands. One of them OBIP(2-(2-bromophenyl)imidazo[4,5-f]-1,10-phenanthroline) and
its Ru(II) complex [Ru(dmp)2(OBIP)]2+ (complex 1) and the other PBIP(2-(4bromophenyl)imidazo[4,5-f]-1,10-phenanthroline) and its Ru(II)
complex[Ru(dmp)2(PBIP)]2+ (complex 2), can be seen in Figure 2. Through theoretical
calculations using Density Functional Theory, it was shown that in complex 1(Br in
number 2 postion), the imidazo[4,5-f]-1,10-phenanthroline moiety is not coplanar with
the 2-bromophenyl ring giving a dihedral angle of 48.2 degrees. Complex 2 (Br in the
number 4 position) is essentially planar with a dihedral angle of 0.4 degrees. Dihedral
angles were measured through geometry optimizations using the DFT-B3LYP method.
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After measuring the binding of the two complexes through spectrophotometric
measurements with calf thymus (CT) DNA, they found that complex 1 binds through a
semi-intercalative binding whereas complex 2 strongly binds through intercalation. This
makes complex 2 a much better choice for selective binding to CT DNA.7

Proven Intercalators
Different attachments to an already planar molecule can determine whether it is
intercalating or nonintercalating. The role different attachments play can be seen in
acridine and proflavin.5 Acridine, Figure 3, is accepted as an intercalating dye, and has
been used to develop acridine drugs.5 These drugs create several biological effects and
include bacterial and antiviral properties, inhibition of DNA and RNA synthesis in vitro,
and RNA synthesis in vivo.5,8 Acridine consists of three coplanar fused aromatic rings.
Coplanar ring systems are considered the general and optimal structure of intercalating
dyes. Intercalating dyes also can contain a charged group or metal ion, allowing
electrostatic interactions between the molecule and DNA. Intercalation of ligands with
DNA is shown in Figure 4.
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Figure 3: Acridine

Figure 4: Ethidium intercalation into DNA.9
When measuring the fluorescence of acridine and bound acridine with DNA, there
is an increase in the fluorescent quantum yield by a factor of three.5 Acridine is an
intercalator and variations on acridine’s structure have also shown to be intercalating, but
small changes in the structure have a dramatic effect on the emission. When amine
groups were added to the (9) position such as in 9-aminoacridine, binding was not
hindered, but when amine groups were added to the 10, 3, and 6 positions, binding
constants were lowered. These positions can be seen in Figure 3. Steric hinderance
seems to be the reason. Also, if the aromatic character of the molecule is lost, binding to
DNA goes down.5
G-C and A-T content also seem to play a role in the fluorescent yield of a bound
dye. Larger G-C content of the DNA quench the fluorescence of bound dyes whereas
5

A-T content plays no role. Kubota, found three classes of acridine dyes that behaved
differently depending on the G-C content of the DNA it was being bound to.5 An
example is the first class of dyes that were tested: 3-aminoacridine, proflavine,
acriflavine, acridine yellow, quinacrine, and 9-aminoacridine. These dyes all showed
quenching of fluorescence as the G-C content of the DNA they were in solution with
increased. The quenching of fluorescence was due to a specific interaction between the
G-C pair and the amino groups of the acridine ring.5
Nonintercalators
An example of the changes that can occur when varying the structure of acridine
is the molecule proflavin. When proflavin, illustrated in figure 5, is bound to DNA its
fluorescent quantum yield decreases by a factor of three. When the acridine is bound to
DNA, the fluorescence quantum yield is increased by a factor of three, which shows that
just a small change in dye structure can cause a large change in fluorescence intensity.
However, it should be noted that any intensity changes when measuring DNA-dye
complexes indicates some interaction. The ligands that were used to determine binding
constants in this research showed a decrease in fluorescence just as proflavin but with
only a slight(few nanometers) red shift.

Figure 5: Proflavin
Once intercalating molecules have bonded to the DNA, stabilization of the ligand
nucleic acid complexes occurs through hydrogen bonding. The ligands have electron rich
nitrogen atoms and oxygen atoms which can form hydrogen bonds with the nitrogenous
6

bases of the double helix.1 Aromatic stacking interactions have also been shown to play a
part in the stabilization. Electrostatic interactions can have some part in the stabilization.
Many other compounds besides acridine have been studied for their binding
characteristics. Ruthenium polypyridine complexes have been studied for their charge
transport exhibiting binding constants on the order of 103 all the way to 109. 10,11,12,13
Aside from intercalating dyes like acridine, there are nonintercalating dyes that
bind to the outside of the DNA helix. An example is the groove binding molecule
Hoescht 33258 (Figure 6), which is one molecule from a family of Hoescht compounds
that are fluorescent stains. These dyes, in general, have shown preferential binding to
A-T base pairs.
The binding of both of these classes of dyes, intercalating and nonintercalating,
have potential for inducing a conformation change and causing a biological response in
the DNA. This is why studying these dyes is of such importance, especially those that
are intercalating. For example, acridine has allowed chemists to develop drugs which
induce several effects when bound to DNA, including: frameshift mutations, antibacterial
and antiviral properties, and inhibition of DNA and RNA synthesis in vitro.2

7

Determining Binding Constant
The six fluorophores used in this research are all aromatic with at least three fused
rings. Classical fluorescence measurements are conducted by titrating small amounts of
DNA into a solution of the dyes and measuring the fluorescence after each addition.
Titrations are the most commonly used studies for finding the binding affinity of the
ligands with DNA, which can only provide information on whether binding is occurring
or not. This type of measurement cannot distinguish the type of binding that may be
occurring.14

Experimental
The studies conducted here consist of binding a class of fluorescent compounds,
synthesized in our lab, with DNA. The fluorophores were created through a reaction of
alpha-diimine compounds to produce fluorescent cations. The reactions can be seen in
Figures 7, 8, and 9 below.

8

N
N

3a R = CO2H
3b R = CO2CH3

4a R = CO2H
4b R = CO2CH3

Figure 8: Second set of reactions to produce 4a-CA, and 4b-CE.

5a

6a

Figure 9: Last reaction to produce molecule QD.

Materials:
Calf thymus DNA was obtained from Sigma Aldrich as Deoxyribonucleic acid sodium
salt from calf thymus. Tris buffer was prepared from Tris(hydroxymethyl)
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aminomethane hydrochloride. Starting materials for reactions were of reagent grade. All
other reagents were used as received from chemical suppliers.

Instrumentation
Absorbance measurements were made using a Cary 50 Scan UV-visible
spectrophotometer to determine concentration. The Centrifuge used was a Beckman
Coulter Allegra 64R. NMR spectra were recorded on GE QE Plus 300 or 400 MHz
Bruker spectrometers. Fluorescent measurements were conducted using either a PC1
photon counting spectrofluorometer or an ISA Spex Fluorolog-t-3-spectrofluorometer.

Preparation of materials

The calf thymus DNA solution was prepared by combining 40 mg calf thymus DNA with
20 mL tris buffer in a 100 mL beaker with a magnetic stirrer. This was allowed to stir for
two hours for thorough mixing. The DNA solution was then centrifuged at 6000 rpm at
4°C for 20 min. The absorbance of the solution was measured to determine the
concentration using calculations from Short Protocols in Molecular Biology.15
The tris buffer solution (.005 M) was prepared by dissolving .788 g tris in 75 mL water.
The pH was monitored while adding 16 drops of 6 M HCl to obtain a pH of 7.40.

Dipyrido[1,2-c:2',1'-e]imidazol-5-ium, 6(dimethylamino)-, perchlorate (2a)(Figure 7)
A solution of 2,2'-bipyridine (Figure 7, 1a) (1.0 g, 6.4 mmol) in 25 mL of
benzene was cooled to 5 oC in an ice bath. To a solution containing 800 mg (6.7 mmol) of
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thionyl chloride in 5 mL of benzene was added 495 mg of DMF (6.8 mmol) in a single
portion. Both solutions were stirred for 5 minutes. The mixture of DMF/thionyl chloride
was added to the bipyridine solution with stirring in a single portion. The addition
produces a yellow solution containing an oily, brown residue. The reaction was stirred for
an additional 15 minutes at 5 oC, then the ice bath was removed and stirring was
continued for an additional 30 min. The oily brown residue gradually solidified over the
course of several minutes. The solid was filtered, allowed to dry, dissolved in water and
filtered. The addition of 5 g of solid sodium perchlorate produced the immediate
formation of a bright yellow precipitate (1.7 g). The precipitate was dried and
chromatographed on alumina (neutral, Brockman Activity I. The salt (Figure 7, 2a)
eluted (acetonitrile) as a broad yellow band. Recrystallization from ethanol (sparingly
soluble) and acetonitrile (soluble), yielded 1.5 g (75 %) of (Figure 7, 2a) as a yellow
crystalline solid.
1

H (300 MHz, DMSO-d6), δ 3.14 (s, 6H, N(CH3)2), 7.49 (m, 4H), 8.61 (d, J=8.89 Hz,

2H), 8.67 (d, J=7.17 Hz, 2H); 13C (75 MHz, DMSO-d6) δ 40.0 (N(CH3)2), 119.32
(double resonance), 120.45, 121.30, 122.33, 127.148. UV (ethanol) 362 (3.5X103), 350
(3.3X103), 284 (8.1X103), 240 (1.4X104) 208 (9.7X103)

Dipyrido[1,2-c:2',1'-e]imidazol-5-ium,6(dimethylamino)-2,10-bis-(carboxy)-,
perchlorate (2b)(Figure 7)
Thionyl chloride (5 mL) was added to a 25 mL round bottom flask fitted with a
magnetic stirrer. The flask was cooled to 0-5 oC, and 488 mg (2.0 mmol) of 4,4'dicarboxy-2,2'-bipyridine. (Figure 7, 1b) was added. The mixture was again brought to 5
11
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C. To the stirred solution, 292 mg (4.0 mmol) of DMF was added in a single portion.

The ice bath was removed, and the solution was refluxed for 10 minutes. The deep
orange solution was cooled to room temperature, and the excess thionyl chloride removed
under reduced pressure (~0.1 torr). The residue was added to 125 mL of water, brought to
a boil, and filtered while hot, then allowed to cool. The addition of 3 g of sodium
perchlorate resulted in the immediate precipitation of (Figure 7, 2b) as a yellow/orange
salt. The mixture was cooled to 5 oC and filtered. Recrystallization from methanol
yielded 640 mg (80%) of (Figure 7, 2b) as orange crystals. 1H (300 MHz, DMSO-d6) δ
3.20 (s, 6H), 7.84 (dd, J=0.86, 7.37 Hz, 2H, H5), 8.76 (d, J=7.37 Hz, 2H, H6), 9.52
(broad s, 2H, H3); 13C (75 MHz, DMSO-d6) δ 39.71 (N(CH3)2), 118.516, 120.803,
121.715, 122.376, 124.866, 130.016, 165.198; IR (KBr) cm-1 1721 (C=O); UV (nm,
ethanol) 416 (2.3X104), 388sh. (1.7X104), 278 (1.1X104), 240 (3.8X104), 208 (2.3X104);
HRFAB m/e calcd for C15H14N3O4 300.0984 found 300. Anal. Calcd for C15H14N3O8Cl
H2O: C,43.1; H, 3.9; N 10.1. Found: C, 43.12; H, 3.79; N 9.99.

Preparation of Dipyrido[1,2-c:2',1'-e]imidazol-5-ium,
bis(methoxycarbonyl)-, perchlorate (2c)(Figure 7)

6(dimethylamino)-2,10-

Thionyl chloride (5 mL) was added to a 25 mL round bottom flask containing a
stirring bar. The flask was cooled to 0-5 oC in an ice bath, and 544 mg (2.0 mmol) of 4,4'carboxymethyl-2,2'-bipyridine (Figure 7, 1c) was added. The mixture was again brought
to 5 oC. To the stirred solution, 150 mg (2.1 mmol) of DMF was added in a single
portion. The ice bath was removed, and the solution was stirred for 30 minutes. The
orange solution was cooled to room temperature, and the excess thionyl chloride removed
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under reduced pressure (~0.1 torr). The residue was dissolved in 75 mL of water and
filtered. The addition of 3 g of sodium perchlorate resulted in the immediate precipitation
of (Figure 7, 2c) as yellow solid. The mixture was cooled to 5 oC and filtered.
Recrystallization from methanol yielded 794 mg (93%) of (Figure 7, 2c) as orange
crystals. Slow crystallization from an acetonitrile solution produced crystals. 1H (300
MHz, DMSO-d6), δ 3.21 (s, 6H), 4.00 (s, 6H, CO2CH3), 7.87 (broad d, J=7.31 Hz, 2H,
H6), 8.80 (d, J=7.38 Hz, 2H, H5), 9.65 (broad s, 2H, H3); 13C (75 MHz, DMSO-d6) δ
39.51 (N(CH3)2), 52.94, 118.10, 120.87, 122.01, 122.59, 123.66, 130.46, 164.14; IR
(KBr) cm-1 1719 (C=O); UV (ethanol) nm 416 (5.0X104), 390sh. (3.7X104), 316
(1.4X104), 276 (2.5X104), 238 (9.0X104) 208 (4.4X104); HRFAB m/e calcd for
C17H18N3O4 328.1297 found 328.1282; Anal. Calcd for C17H18N3O8Cl: C, 47.7; H,
4.2; N 9.8. Found: C, 47.68; H, 4.21; N 9.82.
Anal. Calcd for C15H14N3O8Cl H2O: C,43.1; H, 3.9; N 10.1. Found: C, 43.12; H, 3.79;
N 9.99.

2-(2-pyridyl)-4-carboxyquinoline (3a)(Figure 8) was prepared by mixing isatin (8.0 g)
with acetyl pyridine (6.5 g). 33%, 5°C, NaOH (30 g) was added while mixing continued.
The solution became hot (approximately 65 °C) and started to become solid. Ice water
(30 mL) was then added to give a purple/red slush. This was placed in an ice bath until
the contents were cooled to 5°C. Filtering resulted in a purple/red solid. Washing with
generous amounts of acetone produced a pink/blush color. After allowing the pink
crystals to dry thoroughly, hot water and carbon, from Sigma Aldrich, were added. The
solution crystallized and all colored impurities were removed.
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Pyrido[1',2':3,4]imidazo[1,5-a]quinolin-11-ium, 12 (dimethyamino)-5carboxy)-, perchlorate (4a)(Figure 8)
Thionyl chloride (40 mL) was placed in a 50 mL round bottom flask fitted with a
magnetic stirrer. The resulting solution was then cooled to 5- 10 oC and 5.0 g (20 mmol)
of 2-(2-pyridyl)-4-carboxyquinoline was added with stirring. In a single portion, 40 mmol
(2.92 g) of DMF was added. The solution was then refluxed for 10 min. The heat was
removed, and the deep orange solution was stirred for an additional 15 minutes. The
thionyl chloride was removed under reduced pressure, and the solid was dissolved in 100
mL of water. The solution was filtered and 2 g of solid sodium tetrafluoroborate was
added, producing a bright yellow precipitate. The mixture was cooled to 5 oC, and the
solid filtered. The solid was recrystallized from methanol giving (Figure 8, 4a) as its
tetrafluoroborate salt (8.2 g, 83 %) as a yellow solid. 1H (400 MHz) δ 3.20 (s, 6H), 7.63
(m, 2H), 7.86 (m, 1H), 7.95 (m, 1H), 8.81 (d, 1H, J= 8.9 Hz), 8.85 (d, 1H, 6.9 Hz), 8.94
(d 1H, J= 8.6), 8.99 (d, 1H, J=8.2), 9.04 (d, 1H, J=2.9);
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C (100 MHz, DMSO-d6) δ

39.46, 114.56, 117.59, 118.09, 119.25, 120.32, 120.87, 121.90, 122.73, 122.96, 126.44,
127.26, 128.80, 130.26, 131.37, 166.63; UV (ethanol) nm 388 (1.8X104), 290 (9.3X103),
252 (4.0X104), 208 (2.3X104); HRFAB m/e Calcd for C18H16N3O2 306.1243 found
306.1240 Anal Calcd for C18H16N3O2PF6 C, 47.9; H, 3.6, N 9.3. Found C, 48.17; H 3.5;
N 9.3; Anal Calcd for C18H16N3O2BF4 C, 54.99; H, 4.10, N 10.69. Found C, 53.53; H
4.19; N 10.41;
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Pyrido[1',2':3,4]imidazo[1,5-a]quinolin-11-ium, 12 (dimethyamino)-5methoxycarbonyl)-, perchlorate (4b)(Figure 8)
Thionyl chloride (40 mL) was placed in a 50 mL round bottom flask fitted with a
magnetic stirrer and cooled to 5oC. While in an ice bath, with stirring, 5.3 g (20 mmol) of
2-(2-pyridyl)-4-carboxymethylquinoline (prepared as described above) was added. In a
single portion, 40 mmol (2.92 g) of DMF was added, producing an immediate color
change. The orange solution was allowed to stir in the ice bath for 15 minutes. The ice
bath was removed and the solution was stirred for an additional 30 minutes. The thionyl
chloride was removed under reduced pressure, and the solid was dissolved in 100 mL of
water. The solution was filtered, and 4 g of solid sodium tetrafluoroborate was added,
producing a bright yellow precipitate. The mixture was cooled to 5 oC, and the solid
filtered. The solid was recrystallized from methanol giving (Figure 8, 4b) as its
tetrafluoroborate salt (7.4 g, 86 %) as a yellow solid.
1

H (300 MHz, DMSO-d6) δ 3.25 (s, 6H), 4.0 (s, 3H), 7.65 (dd, J = 6.9, 6.8 Hz, 1H), 7.68

(dd, J = 6.9, 6.8 Hz, 1H), 7.85 (dd, J = 7.6, 7.3 Hz, 1H), 7.95 (dd, J = 7.9, 7.6 Hz, 1H),
8.80 (d, J = 9.7 Hz, 1H), 8.85 (dd, J = 9.7, 7.9, 1H), 8.95 (d, J = 8.6 Hz, 1H), 9.05 (s, 1H);
13

C (100 MHz, DMSO-d6) δ 39.5, 54.0, 116.1, 119.06, 119.09, 120.46, 121.07, 121.24,

122.84, 123.60, 124.01, 126.54, 127.45, 129.32, 130.22, 130.45, 132.70, 166.6; UV
(ethanol) nm 390 (1.9X104), 290 (9.9X103), 252(3.9X104), 208 (2.5X104) HRFAB m/e
calcd for C19H18N3O2 320.1399, found 320.1389. Anal Calcd for C19H18N3O2BF4 C,
56.05; H, 4.46, N 10.32. Found C, 55.83; H 4.60; N 10.26
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Bispyrido[1',2':3,4]imidazo[1,5-a:5',1'-c]quinoxaline-5,12-diium,6,13-bis
(dimethylamino)-,diperchlorate (6a)(Figure 9)
Thionyl chloride (10 mL) was added to a 25 mL round bottom flask in an ice bath. To the
flask was added 569 mg (2.0 mmole) of bis-2,3-(2-pyridyl)quinoxaline and the mixture
was stirred for 5 minutes. DMF (292 mg, 4.0 mmole) was added in a single portion, and
the solution was brought to a boil. The heat was removed and the solution was stirred for
an additional 15 minutes. The thionyl chloride was removed under reduced pressure (~0.1
torr, 25 oC) and the resulting orange-red solid was dissolved in 150 mL of water.
Addition of 3 g of sodium perchlorate produced an orange precipitate which was filtered
and recrystallized from a mixture of methanol and acetonitrile, yielding 792 mg (78%) of
(Figure 9, 6a) as its perchlorate salt. Slow crystallization from an acetonitrile solution
produced crystals.
1

H (400 MHz, DMSO d6) δ 3.27 (s, 6H, N(CH3)2) 7.40 (dd J=6.9, >1 Hz, 2H), 7.52 (d

J=9.3, J <1 Hz, 2H), 8.38 (s, 2H), 8.49 (dd, J=9.4 Hz, J < 1, 2H), 8.60 (dd, 7.5 Hz, J < 1
Hz, 2H);
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C (100 MHz, DMSO-d6, DEPT 90 Correlations) δ 39.50 (CH3) 106.653(C),

114.252(C-H), 118.727(C-H), 119.144(C-H), 120.347(C), 123.599(C-H), 126.421(C-H),
134.338(C); 4.21; N 14.91; UV (ethanol) nm 444 (1.3X104), 300 (1.3X104), 250
(2.5X104), 230 (2.3X104); HRFAB m/e calcd for C24H24N6 396.2062. found 396.2050;
Anal. Calcd for C24H24N6O8Cl2: C,48.4; H, 4.06; N 14.12. Found: C, 48.82; H, 4.21
N, 14.16.
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Procedure for data collection
To prepare the dyes for fluorescent measurements, they were dissolved in 4 mL
acetonitrile. The absorbance was measured to determine the concentration. When other
peaks showed up in the absorbance scan, TLC(thin layer chromatography) was performed
to separate the compounds. Using acetonitrile and a 250 µm glass backed TLC silica gel
plate, the fluorophores separated from other compounds on the plate. The top layer from
the plate was scraped off and a solution was created with acetonitrile. Any undissolved
material was filtered out. UV-Vis was performed again to ensure the correct compound
was obtained. Absorption data can be found in Table 1. Additional dilutions with
acetonitrile were needed for fluorescent measurements. To get the dyes’ concentrations
on scale for fluorecense measurements, approximately 10-6 M, 10 µL dye was added to 2
mL tris buffer (solution 1). Solution 2 was prepared by adding 10 µL dye to 2 mL DNA
solution.
The amount of dye was kept constant to ensure that the concentration of dye
remained the same throughout the titrations. The DNA solution had changing
concentrations depending on the concentration of dye used i.e. if the concentration of dye
used to prepare the solutions was 10-3 M, then the DNA was the same. If the
concentration varied to 2 X 10-3 M, then the DNA concentration was changed to achieve
1:1 ratio of the concentrations. The excitation spectrum was then obtained for each dye
to know where to excite the molecule for the emission spectrum. The fluorescence
titrations began by measuring the fluorescence of solution 1(10 µL dye/2 mL tris buffer).
The consecutive intensity measurements were made after additions of small amounts of
the DNA/dye solution. Additions were made in increments of: 10 µL, 15 µL, 20 µL, 25
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µL, 30 µL, 35 µL, 40 µL, and 45 µL. The maximum emission was plotted after each
addition.

Fluorescent data can be found in Table 1.

Care had to be taken during each of the titrations due to the concentration of
DNA/ligand present. After each addition the sample was drawn into a pipette and
expelled back into the cuvette three times, which ensured mixing and limited loss of
sample. After a titration was finished, the cuvette was washed, rinsed with water and
buffer, and then rinsed with the next starting solution to prevent cross contamination.

Table 1. Data used for fluorescence measurements
Ligand
QD(6a)
BPY(2a)
DE(2c)
DA(2b)
CE(4b)
CA(4a)

Initial concentration
of ligand in cuvette
9.34X106M
1.75X106M
2.99X107M
1.25X106M
1.51X106M
9.05X107M

Absorbance
wavelength (λmax)
398
350
419
395
390
375

Flourescence
wavelength (λmax)
571
540
548
540
512
494

Calculations
Many analytical methods have been published for determining binding constants
of the ligand-DNA complex. The methods of McGee and Von Hippel16 and Rodger and
Norden17 have been proven to work for many spectroscopic techniques. But, with so
many calculations, a lot of time is consumed, and easier methods are available. Recently,
a paper was published in The Analyst which detailed a computer program using Norden
and Rodgers calculations which can be used to deduce binding constants.13 In this
program, spectroscopic data and concentrations are entered, and, within seconds, a
binding constant is generated. The calculations that were chosen for use here were a
combination of calculations outlined in detail and found in two different papers.18,19
18

Binding constants were determined using the graphing program Prism.
LigandT = total concentration of ligand
When DNA is present:
Ligand T = Ligand Free + Ligand Bound
[BP] = Concentration of Base Pairs = [DNA]/2, to get an average concentration of base pairs.
So, LigandT + [BP] 

Ligand B [BP]

Keq =
If [L]B = BPB
Then, Keq =
Looking at emission:
A = εbc
Upon binding:
εobs =
Then, Aobs = εF[L]F + εB[L]B
εobs[L]T = εF[L]F + εB[L]B
εobs[L]T - εF[L]F = εB[L]B and [L]F = [L]T – [L]B
Then, εobs[L]T - εF([L]T – [L]B) = εB[L]B
(εobs - εF)[L]T = (εB - εF) [L]B
[L]B =
So, Ligand bound is expressed as the fractional change in ε (εobs
change in ε X

[L]B =

.
[L]T
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- εF)over the total or maximal

[L]F = [L]T – [L]B = [L]T(1Then, [L]F = [L]T(1-

)

)

Substituting into Equation 1:

Keq =
Assume

so,

K=

=

x(

=

)

=
=

-

or

+

Plot
For emission:

Δઽmax = ΔFmax = FB-FF
Δઽobs= ΔFobs = Fobs-FF
And,

+

1=
1-

=

=

·

=

·
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=

+

Plot

, Slope =

Figure 10:

, Slope =

( Seen in Figure 10.)

.

Results and Discussion:
Table 2. Binding constants and change in fluorescence seen for each ligand.
Ligand
Binding Constant
Total change in F
5
2a(BPY)
Trial 1
2.855X10
-168490
5
Trial 2
2.46X10
-115460
2b(DA)
Trial 1
2.64X104
-58994
4
Trial 2
2.44X10
-78673
5
2c(DE)
Trial 1
6.14X10
-171883
Trial 2
4.79X105
-135878
5
4a(CA)
Trial 1
4.35X10
-239478
5
Trial 2
4.81X10
-229580
4b(CE)
Trial 1
1.12X105
-558649
5
Trial 2
1.05X10
-885750
4
6a(QD)
Trial 1
1.85X10
192521
(1st half)
Trial 1
-4.07X103
210560
(2nd half)
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As can be seen from Table 2, the binding constants for each trial of the same dyes are
very close except for the molecule QD. The following graphs were made using Prism.
The best trial is shown, based on r2 value. The trial number is given in each spectral set.

BPY Trial #2

Intensity

400000

[DNA] = 0
[DNA] = 1.7X10-6

300000

200000

[DNA] = 1.9X10-4

100000

0
400

500

600

700

800

Wavelength(nm)

Figure 11: Graph showing emission decrease upon binding of BPY to DNA.

CA Trial #1

Intensity

1500000

1000000

[DNA] = 1.7X10-6

500000

[DNA] =
1.2X10-4
0
400

500

600

Wavelength(nm)

Figure 12: Graph showing emission decrease upon binding of CA to DNA.
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CE Trial #1
750000

[DNA] = 0

Intensity

[DNA] = 1.7X10-6
500000

250000

[DNA] = 1.2X10-4

0
500

600

Wavelength(nm)

Figure 13: Graph showing decrease in emission upon binding of CE to DNA.

DE Trial #1
300000

Intensity

[DNA] = 0
[DNA] = 2.6X10-7

200000

100000

[DNA] = 1.9X10-5
0
500

600

700

Wavelength(nm)

Figure 14: Graph showing decrease in emission upon binding of DE to DNA.
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DA Trial #1

Intensity

300000

[DNA] = 0

[DNA] = 1.7X10-6

200000

100000

[DNA]
=1.2X10-4

0
500

600

700

Wavelength(nm)
Figure 15: Graph showing decrease in emission upon binding of DA to DNA.
The following graphs depict the plots that solved for K. The slope of the line = -1/K.
Only the trials with the best r2 values were included here.

BPY
0

∆F

-1/slope = K = 2.85X105
r2 = 0.9572
-100000

-200000
-5.0×10 -10-4.0×10 -10-3.0×10 -10-2.0×10 -10-1.0×10 -10 -2048.0

∆ F/.5(DNA)
Figure 16: Graph used to find the binding constant for BPY.
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CA
0

4.36X105
r2 = 0.9551

-1/slope =K =

∆F

-100000

-200000

-300000
-7.8×10 -10 -5.8×10 -10 -3.8×10 -10 -1.8×10 -10

∆ F/.5(DNA)
Figure 17: Graph used to find the binding constant between CA and DNA.

CE
-250000

-1/slope = K = 1.05X105
r2 = 0.9545

∆F

-500000

-750000

-1000000
-7.0×10 -10

-5.0×10 -10

-3.0×10 -10

-1.0×10 -10

∆ F/.5(DNA)
Figure 18: Graph used to find the binding constant between CE and DNA.
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DA
-30000

∆F

-40000

-1/slope =K = 2.45X104
r2 = 0.9340

-50000

-60000

-70000
-1.6×10 -09 -1.4×10 -09 -1.2×10 -09 -1.0×10 -09 -8.0×10 -08

∆ F/.5(DNA)
Figure 19: Graph used to find the binding constant between DA and DNA.

DE
-75000

-1/slope = K = 4.80X105
r2 = 0.9834
∆F

-100000

-125000

-150000
-4.0×10 -10-3.4×10 -10-2.8×10 -10-2.1×10 -10-1.5×10 -10

∆ F/.5(DNA)
Figure 20: Graph used to find the binding constant between DE and DNA.
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QD
500000

∆F

400000
300000
200000
100000
0
0.0

2.0×10 09

4.0×10 09

6.0×10 09

∆ F/.5DNA
Figure 21: QD followed a different pattern from the rest of the molecules studied.
Instead of seeing a decrease in fluorescence after each addition of DNA, there was an
increase and then a decrease. This was seen in both trials. Only trial 1 is shown here.

QD #1
-1/slope = K = -1.86X104
r2 = 0.9219

∆F

500000

250000

0
0.0

2.0×10 09

4.0×10 09

6.0×10 09

∆ F/.5(DNA)
Figure 22: First binding calculation for QD. This calculation comes from the data where
the fluorescence of the solution is decreasing upon addition of DNA.

27

QD #2
750000

-1/slope = K = -4071
r2 = 0.9482
∆F

500000

250000

0
0.0

3.5×10 08

7.0×10 08

1.1×10 09

1.4×10 09

∆ F/.5(DNA)
Figure 23: This graph is the result of the second half of the QD titration in which the
fluorescence was increasing upon addition of DNA.
Fluorescence spectroscopy is just one of many measurements that could have
been conducted. Other quantitative measurements include changes in NMR, UV-Vis,
and circular and linear dichroism. The detection limit is low on a fluoremeter allowing
for low concentrations of the DNA and ligand. The only time a breakdown can occur in
this type of measurement happens because fluorescent measurements assume that any
change in fluorescence occurs because of the bound ligand.
UV-Vis spectroscopy was not used due to the limit detection on a UV-Vis
spectrophotometer and the large quantities of sample required, to complete both UV-Vis
and fluorescence measurements. NMR also requires a large amount of sample.
As can be seen in Table 2, the emission decreased upon the addition of the DNA,
with the exception of QD. Decrease in emission was also seen in the case of proflavin.5
In this research there was a slight red shift, only a few nanometers, which made it
different from proflavin. Toward the beginning of the titrations, the largest change in
fluorescence is seen. With the first few additions, there is the largest decrease in
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fluorescence and from there the changes become less and less. There comes a point
which is different for each ligand that the solution becomes saturated with DNA and the
fluorescence will start to increase and decrease slightly with each addition, not trending
one way or the other. Also, because of the large decrease at the beginning of the titration,
the first few points had to be deleted for most of the ligands. Because of both of these
deletions, for a few of the trials, around a third of the points were deleted. Had time been
allowed after review of this data, many more data points should have been collected in
the middle of the titration. DNA should have been added in smaller increments at first,
8.6 X 10-7 M, then increased to 1.7 X 10-6 M and left there for 10 additions instead of 6,
then increased to 2.6 X 10-6M and left there for 10 additions as well.
As explained earlier, this type of titration cannot be used to determine the type of
binding that is occurring with these ligands and DNA. Standard fluorescent
measurements including intensity measurements cannot distinguish between the different
modes of binding but can detect interactions taking place between the DNA and ligand.
However, inferences can be made from the binding constants and shape and charge of the
molecules. To do this, the molecules are sectioned off into groups. Group 1 are
molecules from the first reaction (Figure 7), group 2 from the second reaction (Figure 8),
and group 3, the last molecule QD (Figure 9).
Group 1 molecules include BPY, DA, and DE. Looking at their structures from
Figure 7, they all appear to have similar structures, 3 aromatic fused rings with different
functionalities on the 2 and 10 positions on the ring. They all also contain charged
nitrogen at the 7 position. This would make it seem that the binding constants would be
similar for all three molecules, but DA had a 104 constant whereas the other two were

29

105. Whereas the charges appear the same, the pH of the buffer solution has to be
considered. At the physiological pH chosen of 7.4, the carboxy groups on the DA
molecule will ionize. This will cause a negative charge at the 2 and 10 positions, giving
an overall charge on the molecule of (-1), and is a likely cause of a decrease in binding
for DA. Negative overall charge will cause it to have less interaction with anionic DNA.
The other two molecules, BPY and DE, in this group, both contain the (+1) charge
needed to interact with the anionic surface of the DNA.
The second group of molecules, CE and CA, don’t behave in the same way as
group 1. Once again they have like structures except for the different substituent’s at the
5 position on the ring. The same thing happens to CA as to DA. At pH=7.4, CA will
ionize and form a negative charge creating a neutral charge overall for the molecule. The
similarities to group 1 end here. Whereas in group 1 the difference in charge created a
lower binding constant, the neutral charge for group 2 actually has a higher binding
constant than the molecule with a positive charge. This leads to the conclusion that
electrostatic effects are not playing a role in the binding of group 2 molecules to DNA.
For QD, a molecule with an overall charge of +2, it would be expected when
considering electrostatic binding that it would bind the best, but the opposite is seen. It
actually had the smallest binding constant of them all but seems to be binding in two
different ways. More of QD’s binding type will be discussed later. This leads to the
conclusion that intercalation or grove binding, as opposed to electrostatic binding is
taking place here.
Another type of binding that can be considered for these molecules is groove
binding. Characteristics of groove binding molecules include an elongated crescent
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shape that interacts with base pairs of DNA in the major or minor grooves. Due to the
molecules not having this crescent shape, this idea did not seem very promising.
The last type of binding considered is intercalation. Intercalating ligands typically
have a planar structure with at least three fused aromatic rings. Stacking occurs between
the intercalator and the DNA base pairs. Intercalating ligands also tend to carry a charge.
This is what allows them to get close to the DNA. One way intercalation is believed to
occur happens when the positively charged dyes gets close to the DNA and displace a
sodium or magnesium ion. A weak electrostatic bond has been formed. From here the
ligand can slide into the hydrophobic inner part of the DNA, between base pairs and
away from the hydrophilic outer environment.
Known and studied intercalators include: acridine, ethidium bromide, proflavin,
daunomycin, and adriamycin. Once bound, these intercalators force base pairs apart,
which causes extension and unwinding of the DNA double helix. This process is
reversible but does inhibit the replication process and ultimately cell division. This is
how these ligands are made into cancer drugs. By stopping the bad cell from replicating,
it is possible to stop the spread of the cancer. So, intercalating ligands, for this type of
chemistry, would seem to be the most important.
Looking at the ligands structure from group 1, BPY and DA are both planar with
their fused rings except for their dimethyl amino groups, which have the nitrogen in the
plain and the methyl groups in the z-direction. The geometry optimization for BPY can
be seen in Figure 24.
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Figure 24: Geometry optimization of BPY.
The last molecule in group 1, DE has two groups out of the plain. The first being
the two methyl groups attached to the nitrogen and one of the ester groups attached at the
2 and 10 positions. Based on this, it would seem like the best intercalator would be BPY
due to the +1 charge that the dyes carries which makes it better than DA and the fact that
it is more planar than DE. In the end, it does have a higher binding constant than DA, but
a lower binding constant (2 or 3X) than DE. Intercalation may not be hindered due to the
one ester group being bent out of the plane. If both are entering from the 2 methyl
nitrogen position then the ester groups could just be sitting outside of the DNA helix.
For the second group of ligands, both CA and CE are mostly planar molecules.
They both have the first phenyl group bent out of the plane, but barely. CE which carries
a +1 charge would seem to have a higher binding constant than neutral CA, but this is not
seen. The data at this point does not fit everything that has been seen in the literature for
the binding that occurs between ligands and DNA. Another set of titrations should be
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done with new solutions to verify that this phenomenon is actually occurring and not an
error on the part of the experiment.
QD is the most interesting of all of the ligands studied thus far. This ligand
carries a +2 charge and is larger than all of the other molecules. The binding is very
different. For the first half of the titration, the emission increased, then for the second
half, the emission decreased. When the decrease occurs, it is possible that QD has
reached a saturation point and so the emission should decrease. QD becomes saturated
with DNA solution, no more binding can occur, and the solution is being diluted, causing
a decrease in emission. Dilution, in the cuvetter, was not considered for the other ligands
studied here, due to the continued decrease in emission, and the fact that they all came to
a point at which the emission intensity was no longer changing. The point at which each
ligand showed no change in emission was considered the saturation point for the rest of
the ligands. The increase in emission for QD, seen in the beginning, may indicate that a
different type of binding is occurring as compared to the other molecules. With the
positive charge QD would have electrostatic interactions with the anionic surface of the
DNA. Because this is the only molecule with a +2 charge, it would seem that, if this is
the only type of binding that is occurring, that the binding constant would be larger than
the others. Because it isn’t, it is concluded that other types of binding are occurring.
The decrease in emission, seen in five of the molecules, was not expected when
these studies began. Compared to other papers read prior to beginning the experiment,
the organic ligands and ruthenium complexes all showed an increase in emission.2,3,13 It
was during experimentation, and after results were in for the molecules studied here, that
other papers were found showing that decreases in emission were also common.2,5,8
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Besides QD, once DNA was added to the mixture and binding began, the
emission immediately decreased. Compared to other studies involving acridine
molecules such as proflavin and acriflavin in which a decrease in emission was shown,
the experimenters used different types of DNA with varying amounts of AT and GC
content. Experimenters were able to see that both of these molecules, proflavin and
acriflavin, decreased linearly with increased GC content.5 In another experiment, the
authors went further and studied the binding of proflavin to individual nucleotides
GMP(Guanosine monophosphate) and CMP(Cytidine monophosphate). In this study they
found that when bound to CMP, proflavin showed a slight increase in emission, but with
GMP they found a strong quencher. The decay curves were non-exponential, which was
attributed to bound and unbound proflavin fluorescence contributions. Also, the curves
obtained when increasing GMP content looked similar to the curves using DNA with
increasing GC content. This leads to the conclusion that guanine is responsible for the
decrease in emission seen upon binding to DNA.
In another study, researchers were able to explain why guanine caused a decrease
in emission in their molecules. In this study, an HGA(glutamine hydroxamate)
compound, La(HGA)3Cl3-2H2O a member of the quinolones family saw a decrease in
emission of 27.6%. Researchers attributed the decrease in emission to the fact that the
HGA becomes a stronger oxidizer when excited by light and guanine, a good electron
donor. The oxidation causes an electron transfer from the guanine base to the
compounds. The HGA compound was investigated through fluorescence and viscosity
studies with ct-DNA(calf thymus DNA) and tris buffer. 23
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From all of this information, perhaps something else is occurring with the
molecules in our study. There is no electron transfer because the molecules are not
electron acceptors. If they had a metal complex this would be a possibility, but without
it, it would not work. It is believed that there is an energy transfer going on that does not
involve transferring an electron.
In the excited state, the electrons of the molecule are in a different configuration
that in the ground state. They will react differently to their surroundings than they would
have in the ground state. There are two things that must be looked at to determine the
effect of the surroundings on the molecule:
1.

The lifetime of the excited state tells how long the molecule is able to react with
its surroundings.

2. The rate that the surroundings are able to interact with the molecule.
Emission is the loss of energy by emitting light from the excited state back to the ground
state. Another way of losing energy is vibrations in the excited state. These vibrations
are how a molecule moves from the initial excitation to the lowest excited state before
emitting a photon. The energy from the vibrations is released as heat to the surrounding
solvent. Energy transfer involves the transfer of energy of one molecule to the electronic
levels of neighboring groups.24
In solution, the molecule would be able to transfer energy to DNA. By losing
energy, some of its fluorescence would be quenched, and it would emit light at a lower
intensity. The other molecules in solution would pick up this energy and the excited
molecule would move to the ground state emitting light of a lower intensity as it had
given energy away. There would be no change in wavelength as the same molecule is
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still fluorescing. An important thing to remember is that these molecules have to be very
close to one another for this energy transfer to occur. The rate of energy transfer is
distance dependent. In a Fluorescence resonance energy transfer (FRET) experiment, it
is believed that for energy transfer to be 50% efficient, the molecules must be within 2060Ǻ24.
To tell if an energy transfer is occurring in the molecules studied here, the
lifetimes and quantum yields must be studied. Lifetimes are the average amount of time
a molecule will spend in the excited state before emitting a photon. Quantum yield of a
molecule is the chance that an excited molecule will return to the ground state after an
emission of a photon. Because there are other pathways for a molecule to return to the
ground state, typical quantum yields are less than one, because one would mean that all
molecules fluoresced. The quantum yield for these molecules decreased upon being in
solution with DNA due to what is believed to be an energy transfer with the DNA. With
this information, it would seem that the longer the lifetime of the molecule in the excited
state, the longer time it would have to give away energy to surrounding molecules. Also,
the bigger change in quantum yield upon being in solution with DNA can tell which
molecules interact more with the DNA. Data for BPY was not available.
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Table 3. Spectral Data for Ligands.
Molecule

Lifetime (ns)

Quantum Yield

Quantum Yield

∆F

in DNA
CE

3.93

.67

Trial 1 - .155

722199

Trial 2 - .154
DE

4.15

.28

Trial 1 - .087

153880

Trial 2 - .092
QD

1.39

.11

Increase-427711
Decrease-235190

CA

4.17

.22

Trial 1 - .182

234529

Trial 2 - .166
DA

4.09

.15

Trial 1- .116

68833

Trial 2 - .127

From the lifetime data compared to the change in fluorescence seen by these
molecules, it seems that the lifetime is playing no part in finding the type of binding that
is occurring. The smallest lifetime has the greatest change in emission and the longest
lifetime has the second to highest change in emission. The lifetime data for these
molecules leads to the conclusion that, because the lifetimes of these molecules are very
similar, the lifetimes are not providing any information on the differences that are seen in
emission.
The quantum yields of the molecules can tell us what molecules are interacting
more strongly with the DNA. The quantum yield for the molecule CE, in water, is .67.
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This means the molecule has a 67% chance of fluorescing after excitation when it is in
solution with water. CE has the largest quantum yield of all of the molecules and also
has the greatest change in emission, which means that CE’s quantum yield is decreased
greatly upon being in solution with DNA. Besides QD, DA has the smallest quantum
yield (.15) and the smallest change in emission, which means that this molecule’s
quantum yield changes the least compared to the rest of the molecules. To find the
change in the quantum yield of these molecules, a ratio can be set up comparing the
quantum yield of the molecule in water and in DNA solution. The change in
fluorescence will give the second quantum yield. This information is included in Table 3.
From Table 3, conclusions can be made about what molecules are interacting
more strongly with DNA. This conclusion can be made due to the fact that all of the
molecules have the same opportunities to interact with the glass and the other solutions.
Assuming there is no interaction with the buffer, DNA would be the only molecule that
the ligands would interact with. According to Table 3, CE interacts more strongly than
do the rest, much more strongly. From a quantum yield of .67 to .154, shows almost a
fourfold decrease. DE is the only other ligand that comes close with more than a
threefold decrease. DA and CA are almost the same with a decrease of 1.2.
This information is very interesting in that it goes back to what was said earlier
about electrostatic interactions. The two ligands that seem to be interacting with DNA
the most, CE and DE, are the two molecules that carry the positive charge. They would
be interacting with the negative backbone of the DNA. The others, DA and CA, carry a
negative and negligible charge respectively. They would have less of an interaction with
a negatively charged molecule, which leads to the conclusion that quite possibly
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electrostatic interactions are playing a part in the amount of intercalation, if this is the
type of binding that is occurring.
It is important to note that these fluorescent titrations completed here are not able
to accurately predict the mode of binding. Mode of binding comes from many different
types of studies. One way to predict mode of binding comes from viscosity studies.
Upon binding to DNA, intercalators cause an unwinding of DNA which causes
lengthening of the DNA strand, which increases the viscosity. By measuring the
viscosity during a titration, it is possible to determine if the molecule is an intercalator.
Groove binding and electrostatic binding do not cause an increase in viscosity. Another
experiment that could be conducted would be including ethidium bromide in the titration.
Because ethidium bromide binds so strongly to DNA, it would be possible to see if the
molecules of interest were competing for intercalation. This experiment would have to
be conducted using a UV-Vis due to the fact that a decrease in emission would be seen.
Since the molecules of interest already see a decrease in emission upon binding to DNA,
the results would give no new information. Using a UV-Vis though, it would be possible
to see if some of the EB was free due to new peaks seen in the absorption spectrum.
Conclusion
There are a lot of possibilities to consider when determining the type of binding
that is occurring and why some molecules decrease in emission while others increase
upon binding to DNA. The important thing to note though is that all of these molecules
have the potential for use no matter the type of binding. Ethidium Bromide increases in
fluorescence upon binding to DNA and is used in agarose gel electrophoresis to detect
DNA. Acridine and many of its derivatives show different modes of binding and
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increasing and decreasing emission upon binding to DNA but all types are used because
of their mutagenicity.25
The ligands studied here are believed to complete an energy transfer in the excited
state after electrostatically interacting with DNA. The energy transfer and electrostatic
interactions is due to many factors, including charge on the molecules, lifetime data,
change in emission, binding constants, and finally, quantum yields. A lot more data
needs to be obtained and reviewed before coming to any type of conclusion on the
importance of these dyes in any field.
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